Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

72 insider filings · Latest: Sep 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 5, 2026Mar 9 8:05 PMMatthew ShieldsEVP, Global Operations
Sale
17,295$31.67$547.7K9,989(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Sale
23,393$32.46$759.4K1,148,212(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Sale
91,345$32.66$3.0M85,755(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Sale
11,277$32.46$366.1K97,590(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Sale
9,098$32.46$295.4K75,010(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Sale
2,675$32.46$86.8K8,461(D)

View →

Mar 5, 2026Mar 5 10:49 PMShields Matthew
Proposed Sale
17,295$31.67$547.7K—

View →

Mar 5, 2026Mar 5 10:43 PMJover Placid
Proposed Sale
14,150$31.67$448.1K—

View →

Mar 5, 2026Mar 5 10:39 PMSavage Brian
Proposed Sale
1,127$31.67$35.7K—

View →

Mar 5, 2026Mar 5 10:32 PMFox Christine
Proposed Sale
7,924$31.67$250.9K—

View →

Mar 5, 2026Mar 5 10:26 PMFrancis Richard D
Proposed Sale
20,025$31.67$634.2K—

View →

Mar 5, 2026Mar 5 10:13 PMHughes Eric A
Proposed Sale
9,533$31.67$301.9K—

View →

Mar 5, 2026Mar 5 10:08 PMDaniell Richard
Proposed Sale
17,295$31.67$547.7K—

View →

Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Sale
128,985$32.36$4.2M123,127(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Sale
1,274$32.36$41.2K2,926(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Sale
442,935$32.36$14.3M1,121,382(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Sale
80,762$32.36$2.6M85,616(D)

View →

Mar 4, 2026Mar 4 10:42 PMFox Christine
Proposed Sale
9,908$32.46$321.7K—

View →

Mar 4, 2026Mar 4 10:36 PMFrancis Richard D
Proposed Sale
23,393$32.46$759.4K—

View →

Mar 4, 2026Mar 4 10:28 PMHughes Eric A
Proposed Sale
11,277$32.46$366.1K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 18, 2026Sep 22 9:01 PMBrian SavageInterim Chief Legal Officer
Option Exercise
4,503$34.700(D)

View →

Aug 21, 2026Aug 25 8:05 PMAmir WeissChief Accounting Officer
Option Exercise
2,500$19.167,502(D)

View →

Aug 3, 2026Aug 5 8:04 PMPlacid JoverSee "Remarks"
Option Exercise
12,827—25,657(D)

View →

Aug 3, 2026Aug 5 8:02 PMEric A HughesSee "Remarks"
Option Exercise
52,744—0(D)

View →

Jun 5, 2026Jun 8 8:07 PMBARER SOL JDirector
Option Exercise
21,739—0(D)

View →

Jun 5, 2026Jun 8 8:06 PMChen LichtensteinDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:06 PMRosemary A CraneDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:05 PMAmir ElsteinDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:04 PMGerald M LiebermanDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:04 PMPerry NisenDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:03 PMRonit Satchi-FainaroDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:03 PMTal Zvi ZaksDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:02 PMRoberto MignoneDirector
Option Exercise
14,492—0(D)

View →

Jun 5, 2026Jun 8 8:01 PMRichard D FrancisPresident and CEO
Option Exercise
13,043—39,130(D)

View →

Jun 3, 2026Jun 4 8:00 PMMatthew ShieldsEVP, Global Operations
Option Exercise
16,195—32,392(D)

View →

May 28, 2026Jun 1 8:16 PMTal Zvi ZaksDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:15 PMRonit Satchi-FainaroDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:13 PMPerry NisenDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:11 PMGerald M LiebermanDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:09 PMAmir ElsteinDirector
Grant/Award
7,242—7,242(D)

View →

Page 1 of 4

Next →